Informations:
Erreur:
ID
30046
Description
Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366); ODM derived from: https://clinicaltrials.gov/show/NCT01368185
Lien
https://clinicaltrials.gov/show/NCT01368185
Mots-clés
Versions (1)
- 05/05/2018 05/05/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
5 mai 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Hypertension NCT01368185
Eligibility Hypertension NCT01368185
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01368185
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
participant was >20 years and <75 years of age on the index date (i.e., the date of initiating mk-0954a therapy)
boolean
C0001779 (UMLS CUI [1])
Hypertensive disease | Losartan Potassium
Item
diagnosed with hypertension and had received mk-0954a 50/12.5 mg for at least 3 months
boolean
C0020538 (UMLS CUI [1])
C0700492 (UMLS CUI [2])
C0700492 (UMLS CUI [2])
Serum uric acid measurement Quantity | Status post Use of Losartan Potassium
Item
had at least one serum uric acid measurements at baseline and one at 3 months after using mk-0954a 50/12.5 mg
boolean
C0455272 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700492 (UMLS CUI [2,3])
C1265611 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700492 (UMLS CUI [2,3])
Records Documented
Item
had the following records documented in the chart during the data collection period:
boolean
C0034869 (UMLS CUI [1,1])
C1301725 (UMLS CUI [1,2])
C1301725 (UMLS CUI [1,2])
Medical History | Comorbidity
Item
medical history and co-morbidities (if available)
boolean
C0262926 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
C0009488 (UMLS CUI [2])
Sitting blood pressure | Serum uric acid measurement | Lipid profile test
Item
sitting blood pressure, serum uric acid, lipid profile test results before and after using mk-0954a 50/12.5 mg
boolean
C0580946 (UMLS CUI [1])
C0455272 (UMLS CUI [2])
C0850354 (UMLS CUI [3])
C0455272 (UMLS CUI [2])
C0850354 (UMLS CUI [3])
Electrolytes measurement, serum | Creatinine measurement, serum | Sugar pre-meal
Item
serum electrolytes, serum creatinine, and pre-meal sugar (if available)
boolean
C0587355 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0007004 (UMLS CUI [3,1])
C1546096 (UMLS CUI [3,2])
C0201976 (UMLS CUI [2])
C0007004 (UMLS CUI [3,1])
C1546096 (UMLS CUI [3,2])
Prescription document Antihypertensive therapy
Item
prescription information of all antihypertensive regimens
boolean
C1521941 (UMLS CUI [1,1])
C0585941 (UMLS CUI [1,2])
C0585941 (UMLS CUI [1,2])
Diuretics | Angiotensin II receptor antagonist
Item
had been treated with diuretic or angiotensin-receptor blockers (arbs) 2 weeks before initiated treatment with mk-0954a 50/12.5 mg
boolean
C0012798 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0521942 (UMLS CUI [2])
Creatinine measurement, serum
Item
serum creatinine >2 mg/dl
boolean
C0201976 (UMLS CUI [1])